Head-to-head · WeighScore
Ambiante Health & Wellness vs Zealthy
The verdict
Ambiante Health & Wellness takes it — 55/100 to 46.7/100.
Ambiante Health & Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ambiante Health & Wellness is a premium, women-focused telehealth practice offering provider-guided compounded GLP-1 care — semaglutide, tirzepatide, and a low-dose "Longevity Microdose" — alongside NAD+,…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ambiante Health & Wellness | Zealthy |
|---|---|---|
| WeighScore | 55/100 | 46.7/100 |
| Grade | C | C |
| Scorecard rank | #449 | #496 |
| Semaglutide | Not disclosed | $286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | Not disclosed | $351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | Coverage not published | 34 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #449 · C
Strengths
- Compounded semaglutide and tirzepatide plus a low-dose GLP-1 "Longevity Microdose" option, all provider-guided
- Concierge model: dedicated provider, direct secure messaging, provider-directed dosing, and structured check-ins
- Every plan bundles compounded medication, provider care, and discreet direct delivery with no hidden fees
- No charge if you are not approved; published support hours (Mon-Fri, 9am-5pm ET) by phone and email
Where it loses points
- GLP-1 program pricing is not published on the site — quoted only after provider review, so cost is not comparable up front
- Compounding pharmacy partners are not publicly named (a transparency gap for medication sourcing)
- No brand-name Wegovy, Zepbound, Mounjaro, or Ozempic — compounded formulations only
- State availability is not published; private-pay only, and the practice serves women, so it is not a fit for everyone
- No LegitScript or PCAB accreditation displayed on the marketing site
Graded #496 · C
Strengths
- Serves 34 states — meaningful nationwide footprint
- Asynchronous model removes friction for patients who don't want a video visit
- Independent licensed prescribers retain full clinical authority
Where it loses points
- Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
- Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
- Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
- Recently rebranded to Gronk Inc. amid active enforcement
- FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.